Related Experiment Video
Updated: Dec 8, 2025

06:52
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
6.8K
Molecular Insights Into Colorectal Carcinoma
Domenika Ortiz Requena1, Monica Garcia-Buitrago2
1Department of Pathology and Laboratory Medicine, Jackson Health System/University of Miami Miller School of Medicine, Miami, Florida, USA.
Archives of Medical Research
|September 23, 2020
Summary
Colorectal carcinoma (CRC) is a common cancer with complex molecular changes. Understanding its genomic, epigenomic, and molecular subtypes is key for improved prognosis and treatment strategies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Colorectal carcinoma (CRC) is a leading cause of cancer-related deaths globally.
- CRC is characterized by a stepwise accumulation of molecular alterations during adenoma progression.
Purpose of the Study:
- To review the genomic and epigenomic pathways in CRC development.
- To describe the four consensus molecular subtypes of CRC.
- To discuss predictive biomarkers for CRC.
Main Methods:
- Review of genomic and epigenomic pathways (chromosomal instability, microsatellite instability, CpG island methylator phenotype).
- Description of the four consensus molecular subtypes of CRC.
- Analysis of molecular characteristics, clinical features, and prognosis.
Main Results:
- Detailed characteristics and prognostic implications of genomic and epigenomic instability pathways.
- Comprehensive overview of the four CRC molecular subtypes, including their development mechanisms and clinical relevance.
- Identification of currently used predictive biomarkers in CRC management.
Conclusions:
- The heterogeneity of CRC necessitates a deep understanding of its molecular underpinnings.
- Molecular subtyping and biomarker analysis are crucial for predicting CRC prognosis and guiding treatment.
- Further research into these pathways and subtypes can enhance therapeutic strategies.
Related Concept Videos
Tumor Progression
7.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K

